Record 2025 Revenue and Profitability
Net revenue grew to $759.4M in fiscal 2025, up 25.3% year‑over‑year. Adjusted EBITDA surpassed $100M for the first time, reaching $114.0M, up 31.6% year‑over‑year. Q4 revenue was $213.6M and Q4 Adjusted EBITDA was $29.2M. Net income for the year was $66.3M, or $1.44 per diluted share.
Strong Gross Profit and Operating Leverage
Gross profit rose to $285.7M, representing a 37.6% gross margin (modest contraction from 37.9% prior year). SG&A was $159.4M (21.0% of net revenue) with SG&A as a percent of sales improving by over 110 basis points year‑over‑year, while marketing investment increased by $10.4M.
Operational Capacity & Systems Upgrades Completed
Brought a third production line at ECS online in October, implemented a new ERP with zero unplanned shipment interruptions, transitioned to a dedicated cold storage facility, and rebuilt inventory. 2025 CapEx was $82M, aligned with prior guidance.
Expanded Farm Network
Farm network expanded to more than 600 small farms committed to pasture‑raised standards, adding approximately 175 farms in 2025—a material expansion of supply capabilities tied to the brand's animal welfare standards.
Brand Awareness and Market Share Gains
Brand awareness increased to 34%, up 8 percentage points in 2025. According to Circana, Vital Farms gained 25 basis points of volume share within MULO+ in 2025 and 35 basis points year‑to‑date through Feb 15, positioning the company as a top share gainer in premium shell egg brands.
Improved Financial Controls and Balance Sheet Strength
Successfully remediated a previously disclosed material weakness in internal controls (no restatement required). Company is debt‑free and ended 2025 with $113.4M in cash and marketable securities, retaining balance sheet flexibility.
2026 Guidance and Long‑Term Targets Reinforced
Introduced 2026 guidance of $900M–$920M net revenue (more than 20% growth at midpoint) and Adjusted EBITDA guidance of $105M–$115M (midpoint ≈12% margin). Reaffirmed long‑term targets: $2B net revenue by 2030, gross margin ≥35%, and Adjusted EBITDA margin 15%–17%. Board authorized a $100M 2‑year share repurchase program.